Shanghai, China, August 28, 2019 - Parkyard Hotel
We're delighted to invite you to our inaugural NASH Summit, focusing on the trends and translational models across NASH drug discovery and development.
As the first therapy for nonalcoholic steatohepatitis (NASH) closes in on approval, further single agent and combination therapy development is extensively ongoing. To improve this development, enhanced preclinical models are needed which better replicate all aspects of human NASH, and improve translation of novel agents to the clinic.
The symposium will bring together NASH R&D and preclinical teams from pharmaceutical and biotech companies to facilitate cross discipline discussions on current techniques, and how to move forward with future approaches.
Discussion Topics Include
- How to apply translational NASH models to enhance preclinical development programs
- Current trends and future opportunities in NASH drug discovery and development
- The progress of NASH research in China
Presentation & Speakers
Attendance is free, but seats are limited, reserve your space by submitting the registration form today!